In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
ID: 350946Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350946

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-24-004.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "In Vivo High-Resolution Imaging for Inner Ear Visualization" (R01 Clinical Trial optional) aimed at advancing imaging technologies for the inner ear. This initiative encourages the development of innovative imaging techniques that enhance the visualization of inner ear structures in living humans, focusing on both structural and functional aspects, and promoting interdisciplinary collaboration among researchers. The funding opportunity, with a total budget of $2 million to support 2-4 awards in fiscal year 2024, is open to a wide range of eligible applicants, including educational institutions and nonprofit organizations, with applications accepted starting January 1, 2024. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DC-24-004-Full-Announcement.html
    RFA-DC-24-004.html
    The National Institutes of Health (NIH) is offering a funding opportunity aimed at advancing in vivo high-resolution imaging technologies for the inner ear, overseen by the National Institute on Deafness and Other Communication Disorders (NIDCD). The initiative (Funding Opportunity Number RFA-DC-24-004) encourages projects to enhance existing imaging methods or develop novel techniques that provide superior visualization of the inner ear’s anatomical and functional structures in living humans. Proposals should leverage interdisciplinary collaboration and can include preclinical animal studies with a clear pathway to human application. Support is available for low-risk clinical trials that do not involve FDA oversight and are primarily research-focused. The application process opens on January 1, 2024, with a total budget of $2 million allocated to fund 2-4 awards in fiscal year 2024. Eligible applicants include various educational institutions, nonprofits, for-profits, and government entities. Criterion for review includes the significance of the research, innovation, investigator qualifications, and overall project approach. This funding opportunity emphasizes the potential of high-resolution imaging to improve diagnosis and treatment of inner ear disorders, ultimately supporting public health and scientific advancement.
    Similar Opportunities
    Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through a cooperative agreement aimed at advancing in vivo high-resolution imaging technologies for inner ear visualization, specifically under the announcement RFA-DC-24-005. This initiative seeks to support high-risk clinical trials that enhance existing imaging techniques or develop new technologies capable of visualizing inner ear structures with significantly greater detail and accuracy in awake patients. The program emphasizes the importance of multidisciplinary collaboration and is particularly focused on projects that may require FDA oversight or involve higher participant risks, with a total funding amount of $2 million available for 2-4 awards, each with a maximum budget of $500,000 per year for up to five years. Interested applicants must submit their proposals by January 1, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems" under the cooperative agreement mechanism (UG3/UH3), aimed at advancing optical imaging technologies to address the challenges of light scattering in biological tissues. This initiative seeks to develop next-generation non-invasive or minimally-invasive optical imaging techniques that enhance penetration depth and resolution, thereby improving diagnostic and research capabilities in biomedical fields. With a total funding commitment of approximately $4.9 million available over a maximum project period of three years, eligible applicants include higher education institutions, non-profits, and small businesses, all of which must submit their proposals electronically through Grants.gov by February 7, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25), aimed at enhancing recruitment into research careers within the biomedical field. This program supports educational activities that provide mentorship and research opportunities for medical students and resident-investigators, addressing the shortage of clinician-investigators in otolaryngology. Eligible applicants include higher education institutions and nonprofits, with a focus on fostering diversity among participants, and funding is capped at $499,999 in direct costs per year for a duration of 12 to 24 months. Interested parties can find more information and apply by contacting NIH Grants Information at grantsinfo@nih.gov, with applications due by September 29, 2026.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) to support R01 grant applications aimed at promoting workforce development among Early Stage and New Investigators in the field of communication disorders. This initiative encourages applications from individuals from diverse backgrounds, particularly those underrepresented in health-related sciences, and allows for innovative research projects without the necessity of preliminary data, provided they demonstrate feasibility. Applicants can request up to $500,000 in direct costs per year, with a total funding commitment of approximately $2.1 million planned for fiscal years 2026 and 2027 to support around 7-8 meritorious projects. Key application dates begin on January 6, 2025, with a closing date of October 6, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support novice researchers in establishing independent careers in biomedical and behavioral sciences, specifically in areas related to hearing, balance, smell, taste, voice, speech, or language. This grant mechanism allows for various research projects, including secondary data analysis and translational research, but cannot be utilized for thesis or dissertation work. The award aims to generate preliminary data to support future R01 applications, with a total funding of up to $375,000 over three years, and applications are due beginning January 19, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-120.html.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" aimed at supporting independent research projects that enhance workforce diversity in health-related sciences. This initiative specifically targets Early Stage and New Investigators from diverse backgrounds, particularly those underrepresented in biomedical, clinical, and social sciences, and does not require preliminary data for application submissions. The NIH intends to commit $2.7 million to this program, with individual awards capped at $500,000 per year for a maximum duration of five years. Interested applicants can find more information and application details at the NIH grants website, and they must submit their applications by February 6, 2025, with the application submission opening on January 28, 2024.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity for research grants aimed at translating basic research into clinical practice, specifically through the R01 Clinical Trial Optional mechanism. This initiative, led by the National Institute on Deafness and Other Communication Disorders (NIDCD), seeks to support projects that convert peer-reviewed basic research findings into clinical applications that enhance human health in relevant mission areas. The anticipated funding amount for each award is up to $500,000, with an expected three awards to be made. The Notice of Funding Opportunity (NOFO) is expected to be published in December 2024, with applications due by February 2025, and awards projected to be made by December 2025. Interested applicants are encouraged to prepare collaborative proposals in advance of the official announcement.